FDA Warns of Slowed-Breathing Risks Associated With Tramadol Use in Children
HHS Announces Loosening of Buprenorphine Patient Limit
Focus on Reducing Opioid Abuse, Misuse May Harm True Chronic Pain Patients
FDA Approves Oxycontin use for ages 11 – 16
Why America Can’t Kick Its Painkiller Problem
Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II
DEA placement of Tramadol into schedule IV